companydata.dkcompanydata.dk

PHARMAVEST ApS: Financial statements 2017

CVR: 26385180

Source: annual report 2017, Danish Business Authority

01/01/201731/12/2017

PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 338,180 and a net result of DKK -260,711 compared with DKK -94,474 the year before. That is a decrease of 29.4% compared with the year before. Equity in the 2017 report amounted to DKK 2,584,545. The solvency ratio was 80.2%. The company had 1 employee in the financial year.

Gross Profit
DKK 338,180
Profit/Loss
DKK -260,711
Equity
DKK 2,584,545
Total Assets
DKK 3,223,198
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-338 t.-261 t.2.6 mio.1
2016-479 t.-94 t.2.8 mio.1
2015-822 t.57 t.2.9 mio.-
2014-926 t.200 t.2.9 mio.-
2013-1.4 mio.416 t.2.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMAVEST ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

FRANK LYDIG HOLDING ApS registered as owner of PHARMAVEST ApSOct 16, 2017

As of October 16, 2017, FRANK LYDIG HOLDING ApS is registered as an owner of PHARMAVEST ApS with an ownership share of 100%.

PHARMAVEST ApS: The 2016 annual report is outMay 26, 2017

PHARMAVEST ApS has published its annual report for 2016. Gross profit came to DKK 479,261, and the net result was DKK -94,474.

About PHARMAVEST ApS

PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.

Source: annual report 2025, Danish Business Authority